"We believe bringing Differin Gel over-the-counter will be a game-changer for consumers and for the acne category," said Miles Harrison, president and GM of Galderma Laboratories, L.P. "We're excited to deliver this new level of efficacy without a prescription to consumers, and to bring the first new active ingredient to the category in over 30 years. As the research and development leader of medically proven dermatologic solutions, Galderma is proud to announce this innovation will be available for people with skin health needs."
There have been only two active ingredients on the over-the-counter market. With the Rx to OTC switch of Differin Gel, millions of people will have easier access to a full prescription-strength product containing a retinoid.
"This landmark approval was years in the making at Galderma and demonstrates our ongoing commitment to individuals with dermatologic concerns such as acne," said Philip Brown, MD, JD, SVP, medical and regulatory affairs, Galderma Laboratories, L.P. "Galderma will continue to partner with healthcare professionals and invest in Rx, OTC and aesthetic and corrective medical innovations to enhance skin health."